Raymond James Financial Services Advisors, Inc. Takeda Pharmaceutical CO LTD Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 25,585 shares of TAK stock, worth $366,121. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,585
Previous 20,648
23.91%
Holding current value
$366,121
Previous $267,000
35.96%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding TAK
# of Institutions
368Shares Held
73MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$190 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$109 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$64.4 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$57.6 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$53.1 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.5B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...